Aslan Pharma raises additional $9m led by MVP Capital Partners; closes Series C at $43m

Aslan Pharma raises additional $9m led by MVP Capital Partners; closes Series C at $43m

Joji Philip

07 January, 2016

Accuron MedTechAccuron TechnologiesAslan PharmaceuticalsBiovedaCenovaHaitong InternationalMorningsideSagamore BioventuresSingaporeTemasekTianda PharmaceuticalsXinChen Ventures

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.